Summary of evidence
-
Effective treatment of allergic
rhinitis improves asthma control and lung
function.<Level II>
-
Measures that have consistently
been reported effective in reducing mite
exposure include hot (>55 degrees C) washing of
all bedding and the use of mite-proof cases for
mattresses and pillows.<Level II>
-
Intranasal corticosteroids are
more effective than antihistamines in
controlling symptoms of allergic rhinitis as
well as non-allergic rhinitis.<Level I>
-
Long-term use of newer
intranasal corticosteroids does not appear to
affect the hypothalamic–pituitary–adrenal (HPA)
axis or cause mucosal atrophy.<Level
II>
-
Specific allergen immunotherapy
is effective in the management of rhinitis and
asthma and can achieve a durable remission of
allergic symptoms. <Level I>
-
Specific allergen immunotherapy
may reduce the risk of childhood rhinitis
progressing to asthma.<Level II>
Note
This information paper is intended to provide information on the clinical
interrelationship between asthma and allergic rhinitis for GPs, asthma
educators, practice nurses and pharmacists. For more information on the
diagnosis and management of allergic rhinitis in primary care, see:
Australasian Society of Clinical Immunology and Allergy. Asthma and
Allergy. Australian Government Department of Health and Ageing 2005
(available at:
www.nationalasthma.org.au).
Acknowledgements
This brochure has been proudly sponsored by

National Asthma Council Australia
ABN 61 058 044 634
1 Palmerston Crescent,
South Melbourne VIC 3205
Tel: 03 8699 0476
Fax: 03 8699 0400
Email:
nac@nationalasthma.org.au
www.nationalasthma.org.au September 2006
Disclaimer
Although all care has been taken, this information paper is a general guide only
which is not intended to be a substitute for individual medical
advice/treatment. The National Asthma Council expressly disclaims all
responsibility (including for negligence) for any loss, damage or
personal injury resulting from reliance on the information contained.

|